Stock Events

Regeneron Pharmaceuticals (REGN) Q4 2022 Earnings

3NovConfirmed
Q1 2022
Q2 2022
Q3 2022
Q4 2022
8.57
12.82
17.07
21.32

Details

Expected EPS
9.56
Actual EPS
11.14
Surprise EPS
1.58
Surprise Percent
+16.53%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 11.14 per share for Q4 2022.

0 Comments

Share your thoughts